22 - CLAP

891. Yao AC, Lind J. Effect of early and late cord clamping on the systolic time intervals of the newborninfant. Acta Paediatr Scand. 1977 Jul;66(4):489-93.Vitamina K892. American Academy of Pediatrics Committee on Fetus and Newborn. Controversies concerning vitaminK and the newborn. Pediatrics. 2003 Jul;112(1 Pt 1):191-2.893. Ansell P, Roman E, Fear NT, Renfrew MJ. Vitamin K policies and midwifery practice: questionnairesurvey. BMJ. 2001 May 12;322(7295):1148-52.894. Autret-Leca E, Jonville-Bera AP.Vitamin K in neonates: how to administer, when and to whom. PaediatrDrugs. 2001;3(1):1-8.895. Brousson MA, Klein MC. Controversies surrounding the administration of vitamin K to newborns: areview. CMAJ. 1996 Feb 1;154(3):307-15.896. Brown SG, McHugh G, Shapleski J, et al. Should intramuscular vitamin K prophylaxis for haemorrhagicdisease of the newborn be continued? A decision analysis. N Z Med J. 1989 Jan 25;102(860):3-5.897. Carmichael A.Vitamin K and childhood cancer. Med J Aust. 1994 Jan 17;160(2):91-2.898. Clarkson PM, James AG. Parenteral vitamin K1: the effective prophylaxis against haemorrhagic diseasefor all newborn infants. N Z Med J. 1990 Mar 14;103(885):95-6.899. Goldschmidt B,Verbenyi M, Kovacs I, Ilin E,Varga K, Nemet T. Prothrombin and acarboxyprothrombinactivity in neonates after oral and intramuscular administration of vitamin K Orv Hetil. 1990 Mar18;131(11):577-82.900. Greer FR.Vitamin K status of lactating mothers and their infants. Acta Paediatr Suppl. 1999Aug;88(430):95-103.901. Handel J, Tripp JH. Vitamin K prophylaxis against haemorrhagic disease of the newborn in the UnitedKingdom. BMJ. 1991 Nov 2;303(6810):1109.902. Hansen KN,Tegllund L, Lange A, Ebbesen F. Late hemorrhagic disease in newborn infants. Is the currentpreventive treatment with oral vitamin K adequate?. Ugeskr Laeger. 1992 Apr 13;154(16):1095-7.903. Hathaway WE, Isarangkura PB, Mahasandana C, et al. Comparison of oral and parenteral vitamin Kprophylaxis for prevention of late hemorrhagic disease of the newborn. J Pediatr. 1991 Sep;119(3):461-4.904. Henderson-Smart DJ. Giving vitamin K to newborn infants: a therapeutic dilemma. 1996 Oct21;165(8):414-5.905. Henderson-Smart D.Vitamin K and childhood cancer. Med J Aust. 1994 Jan 17;160(2):91; authorreply 92.906. Hey E.Vitamin K—what, why, and when. Arch Dis Child Fetal Neonatal Ed. 2003 Mar;88(2):F80-3.907. Isarangkura PB, Bintadish P,Tejavej A, et al.Vitamin K prophylaxis in the neonate by the oral routeand its significance in reducing infant mortality and morbidity. J Med Assoc Thai. 1986 Oct;69 Suppl2:56-61.908. Kay P.The vitamin K controversy. Birth Gaz. 2000 Spring;16(2):19-21.909. Loughnan PM, McDougall PN. The efficacy of oral vitamin K1: implications for future prophylaxis toprevent haemorrhagic disease of the newborn. J Paediatr Child Health. 1993 Jun;29(3):171-6.910. Malik S, Udani RH, Bichile SK, Agrawal RM, Bahrainwala AT,Tilaye S. Comparative study of oralversus injectable vitamin K in neonates. Indian Pediatr. 1992 Jul;29(7):857-9.911. Mathur GP, Mathur S, Goenka R, Bhalla JN, Agarwal A, Tripathi VN. Prothrombin time in first week oflife with special reference to vitamin K administration. Indian Pediatr. 1990 Jul;27(7):723-5.912. McMillan DD. Administration of Vitamin K to newborns: implications and recommendations. CMAJ.1996 Feb 1;154(3):347-9.913. No authors listed. American Academy of Pediatrics Vitamin K Ad Hoc Task Force: Controversiesconcerning vitamin K and the newborn. Pediatrics. 1993 May;91(5):1001-3.MANUAL CLÍNICO AIEPI NEONATAL 122